Through the group’s unique enabling capabilities, the World Without Disease Accelerator (WWDA) supports the Lung Cancer Initiative at Johnson & Johnson. Lung cancer is the leading cause of cancer-related death worldwide, yet five-year survival rates have marginally improved in 25 years.¹ Each WWDA capability group brings forward diverse expertise and insight to apply unique scientific approaches and partnerships with the most promise to prevent or intercept lung cancer at the earliest stage of disease.